Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Beth Campbell
Clinical Research Manager I
Department of Emergency Medicine
Overview
Research
More
Collaboration
(24)
Kurt Denninghoff
Mutual work: 1 Proposal
Collaboration Details
Christian Bime
Mutual work: 3 Proposals﹒3 Grants
Collaboration Details
Bellal Joseph
Mutual work: 2 Proposals
Collaboration Details
Karen Lutrick
Mutual work: 3 Proposals﹒4 Grants
Collaboration Details
Jarrod Mosier
Mutual work: 12 Proposals﹒11 Grants﹒1 Supervisor
Collaboration Details
Page 1 of 5
Previous page
Next page
Grants
(11)
Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous Varespladib Followed by Oral Varespladib in Addition to Standard of Care in Subje
Active
·
2023
·
$0 / $1.5M
·
External
undefined (CD)
pharmaceuticals,
clinical trials,
drug efficacy,
safety assessment,
standard of care
A Phase III, Multicentre, Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tozorakimab (MEDI3506) in Patients Hospitalised for Viral Lung Infec
Active
·
2023
·
$0 / $1.3M
·
External
undefined (CD)
clinical trials,
immunotherapy,
infectious diseases,
respiratory medicine,
drug safety
A Phase 2a, Multi-center, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Alt-100 in Patients With Moderate to Severe Acute Respiratory Distress Syndrome (ARDS)
Active
·
2023
·
$0 / $498.4K
·
External
undefined (CD)
clinical trial,
respiratory distress,
drug efficacy,
safety assessment
Reparixin 1200 Mg Three Times a Day as Add-on Therapy to Standard of Care to Limit Disease Progression in Hospitalised Adult Patients With Covid-19 Other Community-acquired Pneumonia. A Multinational,
Active
·
2023
·
$0 / $302.9K
·
External
undefined (CD)
covid-19,
pneumonia,
therapy,
disease progression,
hospitalized patients
Novel ?2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial
Active
·
2023
·
$0 / $45.8K
·
External
undefined (CD)
thrombolysis,
antiplasmin,
intravascular,
clinical trial,
lysis
Page 1 of 3
Previous page
Next page